Be a part of the Solution
The US Cancer Problem
2+ million
New Cancer Cases
predicted for the year 2025.
2nd
Leading Cause
of deaths in the United States with over 600,000 predicted for 2025.
2.5x
Survivors
more likely to file bankruptcy.
Meet the Community
Member Organizations
Our members drive the success of CancerX, collaborating to set priorities and practices that will help us achieve our mission.
Advisory Leadership
Steering Committee
CancerX’s steering committee provides an additional layer of governance within CancerX’s public-private partnership model.
Xavier Avat, MBA, MBE
Chair of Steering Committee - EVP & Chief Business Officer at Moffitt Cancer Center
Brian Gonzalez PhD
Co-Chair of Steering Committee - Associate Center Director for Research Career Development at Moffitt Cancer Center
Stephen Konya
Chief, Innovation and Strategic Partnerships at U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Technology Policy (ASTP)
Rasu Shrestha, MD, MBA
Chief Innovation & Commercialization Officer at Advocate Health
Ashwini Davison, MD, FACP, FAMIA
Chief Medical Informatics Officer (CMIO) Oncology at Amazon Web Services (AWS)
Megan Shea, MBA
Global Oncology Innovation Lead at AstraZeneca
Sally Werner, MS
Chief Executive Officer at Cancer Support Community
Mary Tolikas, PhD, MBA
Senior VP and CIO at Dana-Farber Cancer Institute
Spencer Ward
Portfolio Director at Elevance Health
Ashita S. Batavia, MD, MS
Head of Hematology & Oncology Data Sciences, Research & Development at J&J innovative Medicine
Andrea Downing
Chief Executive Officer at Light Collective
Cait Brumme, MBA
Chief Executive Officer at MassChallenge
Matt Bettonville
Investor at Yosemite
Edmondo Robinson, MD, MBA, FACP
Founder/CEO at Downeast Digital
Grace Cordovano, PhD, BCPA
CancerX Fellow, Board Certified Patient Advocate at Enlightening Results
